{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:50:08Z","timestamp":1773924608263,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T00:00:00Z","timestamp":1329350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/bjc.2012.47","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T23:51:31Z","timestamp":1329436291000},"page":"1039-1044","source":"Crossref","is-referenced-by-count":75,"title":["Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum"],"prefix":"10.1038","volume":"106","author":[{"given":"D H","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-H","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y S","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B-Y","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-L","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-M","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T W","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-K","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"issue":"5","key":"BFbjc201247_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc1362","volume":"4","author":"MA Bjornsti","year":"2004","unstructured":"Bjornsti MA, Houghton PJ ( 2004 ) The TOR pathway: a target for cancer therapy . Nat Rev Cancer 4 (5) : 335 \u2013 348","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"BFbjc201247_CR2","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/cncr.22195","volume":"107","author":"J Castellvi","year":"2006","unstructured":"Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S ( 2006 ) Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer . Cancer 107 (8) : 1801 \u2013 1811","journal-title":"Cancer"},{"issue":"6","key":"BFbjc201247_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3816\/CGC.2007.n.020","volume":"5","author":"D Cho","year":"2007","unstructured":"Cho D, Signoretti S, Dabora S, Regan M, Seeley A, Mariotti M, Youmans A, Polivy A, Mandato L, McDermott D, Stanbridge E, Atkins M ( 2007 ) Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma . Clin Genitourin Cancer 5 (6) : 379 \u2013 385","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"BFbjc201247_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/156800910791517172","volume":"10","author":"L Ciuffreda","year":"2010","unstructured":"Ciuffreda L, Di Sanza C, Incani UC, Milella M ( 2010 ) The mTOR pathway: a new target in cancer therapy . Curr Cancer Drug Targets 10 (5) : 484 \u2013 495","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"BFbjc201247_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1158\/1078-0432.CCR-08-1253","volume":"15","author":"MC Crouthamel","year":"2009","unstructured":"Crouthamel MC, Kahana JA, Korenchuk S, Zhang SY, Sundaresan G, Eberwein DJ, Brown KK, Kumar R ( 2009 ) Mechanism and management of AKT inhibitor-induced hyperglycemia . Clin Cancer Res 15 (1) : 217 \u2013 225","journal-title":"Clin Cancer Res"},{"issue":"11","key":"BFbjc201247_CR6","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1200\/JCO.2009.26.2923","volume":"28","author":"T Doi","year":"2010","unstructured":"Doi T, Muro K, Boku N, Yamada Y, Nishina T, Takiuchi H, Komatsu Y, Hamamoto Y, Ohno N, Fujita Y, Robson M, Ohtsu A ( 2010 ) Multicenter phase II study of everolimus in patients with previously treated metastatic gastric cancer . J Clin Oncol 28 (11) : 1904 \u2013 1910","journal-title":"J Clin Oncol"},{"issue":"6","key":"BFbjc201247_CR7","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1128\/MCB.19.6.4525","volume":"19","author":"A Dufner","year":"1999","unstructured":"Dufner A, Andjelkovic M, Burgering BM, Hemmings BA, Thomas G ( 1999 ) Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation . Mol Cell Biol 19 (6) : 4525 \u2013 4534","journal-title":"Mol Cell Biol"},{"issue":"1","key":"BFbjc201247_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/labinvest.3700494","volume":"87","author":"M El-Salem","year":"2007","unstructured":"El-Salem M, Raghunath PN, Marzec M, Wlodarski P, Tsai D, Hsi E, Wasik MA ( 2007 ) Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders . Lab Invest 87 (1) : 29 \u2013 39","journal-title":"Lab Invest"},{"issue":"23","key":"BFbjc201247_CR9","doi-asserted-by":"publisher","first-page":"11227","DOI":"10.1158\/0008-5472.CAN-05-2780","volume":"65","author":"M Frattini","year":"2005","unstructured":"Frattini M, Signoroni S, Pilotti S, Bertario L, Benvenuti S, Zanon C, Bardelli A, Pierotti MA ( 2005 ) Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer . Cancer Res 65 (23) : 11227","journal-title":"Cancer Res"},{"issue":"3","key":"BFbjc201247_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/modpathol.3800995","volume":"21","author":"OH Iwenofu","year":"2008","unstructured":"Iwenofu OH, Lackman RD, Staddon AP, Goodwin DG, Haupt HM, Brooks JS ( 2008 ) Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy . Mod Pathol 21 (3) : 231 \u2013 237","journal-title":"Mod Pathol"},{"issue":"14","key":"BFbjc201247_CR11","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF ( 2006 ) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world . J Clin Oncol 24 (14) : 2137 \u2013 2150","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc201247_CR12","first-page":"67","volume":"2","author":"YK Kang","year":"2010","unstructured":"Kang YK, Yoon DH, Ryoo BY, Ryu MH ( 2010 ) Recent advances in chemotherapy for advanced gastric cancer . Asia-Pacific J Oncol Hematol 2 (1) : 67 \u2013 74","journal-title":"Asia-Pacific J Oncol Hematol"},{"issue":"4","key":"BFbjc201247_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00280-007-0516-6","volume":"61","author":"JL Lee","year":"2008","unstructured":"Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Kim M, Chun YJ, Lee JS, Kang YK ( 2008 ) A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy . Cancer Chemother Pharmacol 61 (4) : 631 \u2013 637","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9637","key":"BFbjc201247_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","volume":"372","author":"RJ Motzer","year":"2008","unstructured":"Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Gr\u00fcnwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A ( 2008 ) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial . The Lancet 372 (9637) : 449 \u2013 456","journal-title":"The Lancet"},{"issue":"2","key":"BFbjc201247_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P ( 2005 ) Global cancer statistics, 2002 . CA Cancer J Clin 55 (2) : 74 \u2013 108","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"BFbjc201247_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.ejca.2005.04.022","volume":"41","author":"S Velho","year":"2005","unstructured":"Velho S, Oliveira C, Ferreira A, Ferreira AC, Suriano G, Schwartz Jr S, Duval A, Carneiro F, Machado JC, Hamelin R, Seruca R ( 2005 ) The prevalence of PIK3CA mutations in gastric and colon cancer . Eur J Cancer 41 (11) : 1649 \u2013 1654","journal-title":"Eur J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc201247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201247","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:11:28Z","timestamp":1684415488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc201247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["BFbjc201247"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.47","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}